eNauka - pregled

Pregled prema Autor Smolen, Josef S

Prikaz rezultata 1 do 8 od 8
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2013EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateSmolen, Josef S; Landewé, Robert; Breedveld, Ferdinand C; Buch, Maya; Burmester, Gerd; Dougados, Maxime; Emery, Paul; Gaujoux-Viala, Cécile; Gossec, Laure; Nam, Jackie;
Ramiro, Sofia; Winthrop, Kevin; de, Wit Maarten; Aletaha, Daniel; Betteridge, Neil; Bijlsma, Johannes W J; Boers, Maarten; Buttgereit, Frank; Combe, Bernard; Cutolo, Maurizio; Damjanov, Nemanja ; Hazes, Johanna M W; Kouloumas, Marios; Kvien, Tore K; Mariette, Xavier; Pavelka, Karel; van, Riel Piet L C M; Rubbert-Roth, Andrea; Scholte-Voshaar, Marieke; Scott, David L; Sokka-Isler, Tuulikki; Wong, John B; van, der Heijde Désirée;
Naučni članak
21aM21a - Rad u međ. časopisu izuzetnih vrednosti
2023EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update (✓)Smolen, Josef S; ...; Ristic, Gorica G  ; ...; (broj, koautora 48)Naučni članak
21aM21a - Rad u međ. časopisu izuzetnih vrednosti
2019Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 studySmolen, Josef S; Pangan, Aileen L; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Vargas, Juan Ignacio; Zhang, Ying; Damjanov, Nemanja ; Friedman, Alan; Othman, Ahmed A;
Camp, Heidi S; Cohen, Stanley;
Naučni članak
21aM21a - Rad u međ. časopisu izuzetnih vrednosti
2023Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 260 Weeks from the Select-Monotherapy StudySmolen, Josef S; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Ignacio, Vargas Juan; Damjanov, Nemanja S; Jain, Manish; Kato, K; Carter, K; Khan, N;
Camp, Heidi S; Cohen, Stanley B;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2020Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 WeeksSmolen, Josef S; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Vargas, Juan; Damjanov, Nemanja S; Jain, Manish; Song, Yanna; Khan, Nasser; Enejosa, Jeffrey;
Cohen, Stanley B;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2020Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks from the Select-Monotherapy StudySmolen, Josef S; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Vargas, Ignacio J; Damjanov, Nemanja S; Jain, Manish; Song, Yanna; Khan, Nasser; Enejosa, Jeffrey;
Cohen, Stanley B;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2019Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 WeeksSmolen, Josef S; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Ignacio, Vargas Juan; Damjanov, Nemanja S; Jain, Manish; Sui, Yunxia; Enejosa, Jeffrey; Pangan, Aileen L;
Camp, Heidi S; Cohen, Stanley B;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2019Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 Weeks from the Select-Monotherapy StudySmolen, Josef S; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Ignacio, Vargas Juan; Damjanov, Nemanja S; Jain, Manish; Sui, Yunxia; Enejosa, Jeffrey; Pangan, Aileen L;
Camp, Heidi S; Cohen, Stanley B;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.